DnB Asset Management AS Sells 3,781 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

DnB Asset Management AS lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 13.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,472 shares of the company's stock after selling 3,781 shares during the quarter. DnB Asset Management AS's holdings in Henry Schein were worth $1,624,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in HSIC. Cerity Partners LLC lifted its stake in Henry Schein by 12.3% in the 3rd quarter. Cerity Partners LLC now owns 26,339 shares of the company's stock worth $1,920,000 after acquiring an additional 2,894 shares in the last quarter. Glenmede Trust Co. NA lifted its position in shares of Henry Schein by 13.3% in the third quarter. Glenmede Trust Co. NA now owns 11,257 shares of the company's stock worth $821,000 after purchasing an additional 1,324 shares in the last quarter. Public Sector Pension Investment Board boosted its holdings in shares of Henry Schein by 8.1% during the third quarter. Public Sector Pension Investment Board now owns 5,336 shares of the company's stock worth $389,000 after purchasing an additional 400 shares during the period. PEAK6 Investments LLC boosted its holdings in shares of Henry Schein by 272.9% during the third quarter. PEAK6 Investments LLC now owns 7,817 shares of the company's stock worth $570,000 after purchasing an additional 12,337 shares during the period. Finally, Martingale Asset Management L P purchased a new position in Henry Schein during the third quarter valued at approximately $222,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Buying and Selling

In related news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded down $1.12 during trading on Friday, reaching $65.47. The stock had a trading volume of 2,362,489 shares, compared to its average volume of 1,585,938. The stock has a fifty day simple moving average of $73.96 and a two-hundred day simple moving average of $72.58. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52 week low of $63.00 and a 52 week high of $82.49. The firm has a market capitalization of $8.13 billion, a price-to-earnings ratio of 26.94, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the business earned $0.66 EPS. The business's revenue was up 5.8% compared to the same quarter last year. As a group, analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of a number of research reports. Barrington Research reissued an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. UBS Group dropped their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company started coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Finally, Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.